Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Business Overview: The Company operates 202 outpatient physical and occupational therapy clinics across 34 states, with a concentration in Texas, Michigan, Wisconsin, Florida, Virginia, and New Jersey. Services include pre- and post-operative care for orthopedic and sports-related injuries. Revenue is primarily derived from commercial health insurance (27.7%), managed care programs (28.8%), workers' compensation (17.5%), and Medicare/Medicaid (21.2%).
Key Financial Metrics
| Metric ($ in thousands) | 2002 | 2001 |
|---|---|---|
| Net Revenues | $94,739 | $80,948 |
| Operating Income | $18,874 | $16,948 |
| Net Income | $8,488 | $7,071 |
| Earnings Per Share (Diluted) | $0.67 | $0.55 |
| Cash and Cash Equivalents | $7,610 | $8,121 |
| Net Cash Provided by Operating Activities | $19,524 | $15,172 |
| Total Assets | $41,033 | $36,742 |
| Long-Term Debt | $2,350 | $3,021 |
| Current Ratio | 8.10 | 6.03 |
Margins: Operating income margin was approximately 19.9% in 2002 compared to 20.9% in 2001. Net profit margin was 8.9% in 2002 compared to 8.7% in 2001.
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 17.2% ($13.8 million) driven by a 15% increase in patient visits (1,004,000 in 2002 vs. 871,000 in 2001). The addition of 40 new clinics contributed $2.9 million to revenue growth.
- Expense Increases: Salaries and related costs rose 19% to $42.2 million, primarily due to staffing increases at mature clinics and bonuses. Corporate office costs increased 24% to $11.3 million due to personnel additions and legal fees.
- Debt Reduction: Long-term debt decreased due to the conversion of $667,000 of Series C Convertible Subordinated Notes into common stock in June 2002. The remaining principal balance is $2.3 million.
- Share Repurchases: The Company repurchased 795,600 shares of common stock for $10.5 million in 2002.
- Accounting Change: Implementation of EITF 00-23 required reclassifying $306,000 of minority interest in earnings to salaries and related costs for partnerships formed after January 18, 2001. This had no effect on net income.
Guidance, Outlook, and Risks
Outlook: Management plans to open between 40 and 45 new clinics in 2003, contingent on identifying suitable locations and therapists. New clinics typically incur initial operating losses before becoming profitable.
Key Risks and Contingencies:
- Medicare Cap: A $1,590 annual cap on Medicare reimbursement per patient is scheduled to take effect July 1, 2003. If not repealed by Congress, this could reduce 2004 income by up to 10%.
- Reimbursement Rates: Dependence on third-party payors (79% of revenue) exposes the company to cost-containment initiatives and rate reductions by insurers and managed care organizations.
- Regulatory Compliance: Extensive federal and state regulations (HIPAA, Stark Law, Fraud and Abuse Law) pose risks of penalties or exclusion from government programs if compliance fails.
- Recruitment: Growth is dependent on recruiting experienced therapists with established physician referral networks.
Investor Verification Checklist
- Verify the status of legislation (S569/HR1125) regarding the repeal of the Medicare therapy cap effective July 2003.
- Monitor the conversion status of the remaining $2.3 million Series C Convertible Notes due June 30, 2004, and the company's cash position to repay them if not converted.
- Review the actual number of new clinics opened in 2003 against the guidance of 40-45 and their time-to-profitability.
- Assess the impact of the new share repurchase program (250,000 shares authorized Feb 2003) on future earnings per share.
- Confirm ongoing compliance with HIPAA privacy and security standards (deadlines April 2003 and April 2005).